$AZTR News

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

AZTR: More Background on Cosmetic Opportunity

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

Anitra Q1 EPS $(0.25) Misses $(0.12) Estimate

Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Why Are Shares Of Azitra Rising?

Azitra Inc. (AZTR) Surges Over 44% After Hours— Here's Why It's Trending

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Azitra shares are trading higher after the company announced that it has entered into a securities purchase agreement with new and existing institutional investors worth up to $31.4 million in gross proceeds.

Azitra shares are trading higher after the company announced that it has entered into a securities purchase agreement with new and existing institutional investors worth up to $31.4 million in gross proceeds.

Azitra Enters SPA With New And Existing Investors, Secures Up To $31.4M In Convertible Preferred Stock And Warrants To Launch Innovative Protein And Peptide Research For Cosmetic And Cosmeceutical Markets

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Azitra Receives Noncompliance Notice From NYSE

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Watching Azitra; Zacks Small-Cap Research Gives Stock $1.70/Share Price Valuation

AZTR: New Site for ATR-04 Trial

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Anitra Q4 EPS $(0.81) Misses $(0.33) Estimate

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash